The imports of pacemakers for stimulating heart muscles to the US are experiencing a steady growth trajectory. For the years 2024 through 2028, annual values are predicted to increase marginally. Year-on-year growth rates remain modest, with a slight upwards trend averaging around 0.88% over the five-year period from 2024 to 2028, indicative of a consistent market demand. While in 2023, the imports stood at an estimated 222.8 thousand, the forecasted values show a stable increase.
Future trends to watch for include potential advancements in pacemaker technology and healthcare policies impacting import regulations. Additionally, demographic shifts, such as an aging population, could further amplify demand. Monitoring these factors can provide insight into further changes in import volumes and market adaptation strategies.
